DC260126
| Overview | |
| Catalog # | bs-82308c-5mg |
| Product Name | DC260126 |
| Specifications | |
| Storage Buffer | Brown waxy solid |
| Storage Condition | -20°C |
| Target | |
| Product Information | A GPR40 receptor antagonist1. Suppresses fatty acid-induced elevation of intracellular Ca++. Inhibits palmitic acid potentiated glucose–stimulated insulin secretion in Min6 pancreatic β cells in vitro. Lowers serum insulin levels, increases insulin sensitivity2 in obese Zucker rats (6 mg/kg)2. Reduces pancreatic β cell apoptosis in obese diabetic (db/db) rats3. Protects Min6 β cells from palmitic acid-induced ER stress and apoptosis4 |
| Description | CAS Number: 346692-04-4 Chemical Name: N-(4-Butylphenyl)-4-fluorobenzenesulfonamide Molecular weight: 307.37 Formula: C16H18NO2S Solubility: DMSO (80 mg/ml) Ethanol (80 mg/ml) Physical Properties: Brown waxy solid Purity: 98% by HPLC NMR (Conforms) |
Frequently asked questions
Which applications is DC260126 (bs-82308C) validated for, and at what dilution?
bs-82308C is validated for Life Science( N/A).
How should bs-82308C be stored?
-20°C Storage buffer: Brown waxy solid